Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.

Publication Type:

Journal Article


Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Volume 26, Issue 30, p.4912-20 (2008)


2008, Adult, Aged, Center-Authored Paper, Clinical Research Division, Disease-Free Survival, Female, Flow Cytometry Core Facility, Follow-Up Studies, Graft vs Host Disease, hematopoietic stem cell transplantation, Humans, Leukemia, Lymphocytic, Chronic, B-Cell, Male, Middle Aged, Models, Statistical, Remission Induction, Research Trials Office Core Facility - Biostatistics Service, Risk Assessment, Shared Resources, Survival Rate, Transplantation, Homologous, Treatment Outcome, Whole-Body Irradiation


We reported encouraging early results of allogeneic hematopoietic cell transplantation (HCT) after nonmyeloablative conditioning in 64 patients who had advanced chronic lymphocytic leukemia (CLL). Here, we have extended the follow-up to a median of 5 years and have included data on an additional 18 patients.